U.S. Marine and Shipping Stock News

Gloo Holdings (GLOO) recently completed a follow on equity offering, raising US$22.75 million through the sale of 7,000,000 Class A Common Stock shares at US$3.25 each, a US$0.195 discount per share. See our latest analysis for Gloo Holdings. The follow on offering comes after a period of pressure on Gloo Holdings' share price, with the stock down 15.6% on a 7 day share price return basis and 54.6% over 90 days. The latest close at US$3.36 suggests that short term momentum has been fading. If...

Wells Fargo (WFC) opened Q2 2026 with total revenue of US$21.7 billion and basic EPS of US$2.02, backed by net income of US$6.2 billion for the quarter. Over recent periods the company has seen quarterly revenue move from US$19.8 billion in Q2 2025 to US$20.3 billion in Q1 2026 and then to US$21.7 billion in the latest quarter, while basic EPS moved from US$1.61 to US$1.62 and now US$2.02. This sets up a results season where investors will focus on how these earnings translate into sustaining...

Tariffs on Brazilian imports are shaking up expectations across U.S. industrial and manufacturing stocks, and investors are asking which companies could quietly benefit or face new headwinds as global trade friction rises. This article looks at how the new 25% tariff regime and the possibility of even higher Section 301 duties might filter through supply chains, pricing power, and competitive positioning. To make that idea concrete, it will walk through 3 stocks from a U.S. Domestic...

Winmark (WINA) is back in focus after reporting second quarter and first half 2026 results, with modest revenue growth, slightly lower earnings and a fresh quarterly dividend declaration that may interest income focused investors. See our latest analysis for Winmark. Despite the earnings and dividend news, Winmark’s recent share price performance has been weaker, with the share price down 6.4% over the past month and 6.2% year to date, while the 5 year total shareholder return of 105.0%...

Syndax Pharmaceuticals (SNDX) put its research pipeline in the spotlight with an R&D event focused on new oncology and fibrosis projects, a development that has drawn fresh attention to the stock. See our latest analysis for Syndax Pharmaceuticals. The R&D event comes after a mixed stretch for Syndax Pharmaceuticals, with the share price down 2.53% over the last day and 4.23% over the past week, but showing a 27.27% 1 month share price return and a 1 year total shareholder return of 154.27%...

Oil-Dri Corporation of America (ODC) is back on investors’ radar after growth tied to demand in its fluids purification and premium cat litter businesses, supported by vertical integration, manufacturing investments, and a solid balance sheet. See our latest analysis for Oil-Dri Corporation of America. At a share price of $102.55, Oil-Dri Corporation of America has seen strong momentum, with a 30 day share price return of 9.20% and a year to date share price return of 111.66%, alongside a 5...

Earlier this week, AM Best revised its outlook to negative from stable while affirming the existing credit ratings for Safety Insurance Group and its key subsidiaries, citing pressures from loss severity, weather-related events, and the impact of new business on underwriting results. In a separate development, affiliates of The Plymouth Rock Company reported an open-market sale of 34,272 Safety Insurance Group shares, while continuing to indirectly hold a large aggregate position and...

Over the past six months, Genesis Energy released softer quarterly results alongside a multi-year revenue decline, weaker gross margins than sector peers, and elevated debt levels, prompting investors to reassess the company’s fundamentals. This combination of shrinking revenue, structurally thin margins, and higher financial leverage has raised questions about the resilience of Genesis Energy’s business model relative to alternatives. With these concerns about low gross margins in mind,...

Recent commentary on Bank of Hawaii highlights weak net interest income growth, a low net interest margin and minimal earnings per share growth, raising fresh questions about the bank’s loan profitability and earnings power as of mid‑2026. An interesting angle is that these profitability concerns are emerging while the bank’s shares still trade at a premium valuation to peers, sharpening investor focus on the strength of its underlying fundamentals. We’ll now examine how concerns about Bank...

Northern Trust has been appointed by Invesco to administer and provide custody for new Irish domiciled index tracking mutual funds. The mandate covers a synthetic index replication structure that extends an approach previously used in ETFs to a wider mutual fund investor base in Europe. Northern Trust, traded as NasdaqGS:NTRS, is adding this new Invesco mandate at a time when its stock has seen strong recent returns. The shares closed at $191.125, with the stock up 6.2% over the past week,...

Earlier this week, Taysha Gene Therapies announced an underwritten public offering of 32.5 million common shares at US$6.00 each after releasing updated Part A REVEAL study data for TSHA-102 in Rett syndrome. The new REVEAL data positions TSHA-102 as a potential first disease-modifying gene therapy for Rett syndrome, which could be important for both patients and Taysha’s gene therapy platform. With fresh REVEAL Part A data supporting TSHA-102’s disease-modifying potential, we’ll examine how...

UnitedHealth Group is facing expanded U.S. Department of Justice antitrust scrutiny focused on its Claritev health technology unit. The DOJ has reportedly issued new civil investigative demands that include allegations of collusion with major insurers. The investigation now addresses both market competition and pricing practices, going beyond the company’s previously disclosed antitrust matters. UnitedHealth Group, traded on the NYSE as NYSE:UNH, is coming under closer regulatory attention...

Lakeland Financial stock has delivered a 22.3% total return over the past three years, yet its current valuation signals are split, with the Excess Returns intrinsic value estimate pointing to meaningful upside while earnings based multiples suggest the shares are on the expensive side. That tension leaves investors weighing a stock that screens as 37.0% undervalued on one model but overvalued on traditional ratios, with a mixed overall value score. Over the past three years, Lakeland...

Olin and Huntsman received SEC effectiveness for their joint S-4 Registration Statement. This advances their planned merger of equals to form a combined chemicals company valued at over $12b. The S-4 effectiveness is a key step toward closing the transaction, subject to remaining approvals and conditions. For investors watching Olin (NYSE:OLN), the SEC’s sign off on the S-4 comes as the stock trades around $21.86. The shares are up 4.1% over the past week, but down 13.6% over the past...

We can readily understand why investors are attracted to unprofitable companies. For example, Century Therapeutics...

Insiders who acquired US$128.6k worth of Quoin Pharmaceuticals, Ltd.'s ( NASDAQ:QNRX ) stock at an average price of...

The United States market has remained flat over the past week but has seen a significant increase of 21% over the past year, with earnings projected to grow by 18% annually. In this context, identifying promising small-cap stocks with notable insider activity can offer unique opportunities for investors seeking to capitalize on potential growth within a dynamic market landscape.

The United States market has remained flat over the past week but has experienced a significant 21% rise over the last year, with earnings projected to grow by 18% annually. In this context, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability, positioning themselves well to capitalize on future opportunities in a dynamic economic environment.

In the last week, the United States market has been flat, yet it has seen a 21% increase over the past year with earnings forecasted to grow by 18% annually. In this context of growth and stability, identifying stocks trading below their intrinsic value can present potential opportunities for investors looking to capitalize on undervalued assets.

In the last week, the market has been flat, but it is up 21% over the past year with earnings expected to grow by 18% per annum over the next few years. In this environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong internal confidence and alignment with shareholder interests.

Over the last 7 days, the United States market has remained flat, though it has risen 21% over the past year with earnings forecasted to grow by 18% annually. The term 'penny stocks' might feel like a relic of past market eras, but the potential they represent is as real as ever. Typically referring to smaller or relatively new companies, these stocks can provide a mix of affordability and growth potential when paired with strong financials.

In the last week, the United States market has been flat, yet it remains up 21% over the past year with earnings forecasted to grow by 18% annually. In this environment, dividend stocks can offer a compelling opportunity for investors seeking steady income and potential capital appreciation.

Investors who take an interest in Greenfire Resources Ltd. ( NYSE:GFR ) should definitely note that the Independent...

With the business potentially at an important milestone, we thought we'd take a closer look at NRx Pharmaceuticals...